Arcturus Therapeutics to Attend Upcoming Investor Conference Read more about Arcturus Therapeutics to Attend Upcoming Investor Conference
Arcturus Therapeutics to Report Fourth Quarter and Fiscal Year 2025 Financial Results and Provide Corporate Update on March 3, 2026 Read more about Arcturus Therapeutics to Report Fourth Quarter and Fiscal Year 2025 Financial Results and Provide Corporate Update on March 3, 2026
Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference Read more about Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Arcturus Therapeutics to Attend Upcoming Investor Conference Read more about Arcturus Therapeutics to Attend Upcoming Investor Conference
Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress Read more about Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress
Arcturus Therapeutics to Attend Upcoming Investor Conferences Read more about Arcturus Therapeutics to Attend Upcoming Investor Conferences
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025 Read more about Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025
Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis (CF) Program Read more about Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis (CF) Program
Arcturus Therapeutics to Attend Upcoming Investor Conferences Read more about Arcturus Therapeutics to Attend Upcoming Investor Conferences
Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress Read more about Arcturus Therapeutics Announces Second Quarter 2025 Financial Update and Pipeline Progress